Makena Focus of FDA, Company Square Off

TUESDAY, Oct. 18, 2022 -- In a three-day hearing that began Monday, a U.S. Food and Drug Administration advisory committee will give the maker of a drug meant to prevent premature births a chance to show why its drug should not be pulled off the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news